Type 2 inflammation impacts people in different ways throughout the body, contributing to diseases such as asthma and atopic dermatitis. 23% of adults with moderate-to-severe AD have more than one coexisting type 2 inflammatory disease, which can make the burden even greater. Sanofi | Regeneron

We’re working with Sanofi to address diseases caused by Type 2 inflammation such as atopic dermatitis, asthma, and eosinophilic esophagitis. | Regeneron